Clinical Trial Update: Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing mFOLFOX6 + panitumumab and 5-FU/LV + panitumumab in chemotherapy-naïve unresectable advanced recurrent colorectal carcinoma completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Carcinoma

Drugs mentioned

• 5-FU/LV (5-fluorouracil with leucovorin)
• MFOLFOX6
• Panitumumab (panitumumab)

Snippet

Sponsor: Takeda | Conditions: Colorectal Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2019-03-01